A Simple Key For zanubrutinib Unveiled
Ibrutinib, as just one agent, is helpful in dealing with CLL, distinctive subtypes of lymphoma together with other B-cell malignancies Until unacceptable toxicity or disease progression is noticed. Because of Serious exposure of ibrutinib all through treatment, lymphoma cells could achieve compensatory survival pathways, genetic mutations or clonal